https://scholars.lib.ntu.edu.tw/handle/123456789/521793
標題: | Epidemiology of multiple myeloma in Taiwan: Increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years | 作者: | SHANG-YI HUANG MING YAO JIH-LUH TANG WEN-CHUNG LEE WOEI TSAY ANN-LII CHENG Wang C.-H. YAO-CHANG CHEN MING-CHING SHEN HWEI-FANG TIEN |
公開日期: | 2007 | 卷: | 110 | 期: | 4 | 起(迄)頁: | 896-905 | 來源出版物: | Cancer | 摘要: | BACKGROUND. The incidence of multiple myeloma (MM) is lower in Asia than in western countries. However, no data are available on descriptive epidemiology of MM in Chinese. METHODS. From 1979 to 2003, 3602 MM patients were registered in the Taiwan National Cancer Registry. The annual incidence and mortality were calculated and age-standardized to the world standard population in the year 2000. Age-period-cohort effects on incidence were analyzed. The salient clinical data of 526 MM patients in a single institute were also investigated. RESULTS. From 1979 to 2003, the average age-adjusted incidence per 100,000 population was 0.75. The incidence increased with age to a peak of 5.2 in those aged 75-79 years. In addition to age, remarkable period and birth cohort effects were found to contribute to increased incidence of MM. The age-adjusted mortality also increased, which accounted for an average of 0.59 per 100,000 deaths; however, the fatality rate was steady at 80%. Clinical and laboratory characteristics and treatment outcomes of the 526 MM patients were similar to those reported elsewhere. Remarkably, extramedullary myeloma (extra-MM) at diagnosis was more common in patients younger than 55 years of age than in others (43% vs 13%, P < .001). CONCLUSIONS. Incidence of MM in Taiwan has dramatically increased in recent years and is associated with a birth-cohort effect. There are no apparent differences in treatment outcome between MM patients in Taiwan and in other countries. However, prevalence of extra-MM is higher in patients younger than 55 years of age. ? 2007 American Cancer Society. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-34547903585&doi=10.1002%2fcncr.22850&partnerID=40&md5=f293e32c029360e0b589d16b65411692 https://scholars.lib.ntu.edu.tw/handle/123456789/521793 |
ISSN: | 0008-543X | DOI: | 10.1002/cncr.22850 | SDG/關鍵字: | cyclophosphamide; dexamethasone; doxorubicin; melphalan; prednisolone; vincristine; adult; aged; article; birth cohort analysis; cancer incidence; cancer registry; cancer survival; cohort analysis; combination chemotherapy; disease association; extramedullary multiple myeloma; fatality; female; human; major clinical study; male; mortality; multiple myeloma; prevalence; priority journal; standardization; Taiwan; treatment outcome; Adult; Age Distribution; Age Factors; Aged; Aged, 80 and over; Female; Humans; Incidence; Male; Middle Aged; Multiple Myeloma; Prevalence; Survival Analysis; Taiwan; Treatment Outcome |
顯示於: | 流行病學與預防醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。